Ad is loading...
JAMVX vs JVMSX
JAMVX vs JVMSX Comparison
Open Charts JAMVX vs JVMSX
Janus Henderson VIT Mid Cap Value Instl
Price$17.91
Change+$0.19 (+1.07%)
VolumeN/A
Net Assets107.83M
JHancock Disciplined Value Mid Cap R2
Price$26.42
Change+$0.26 (+0.99%)
VolumeN/A
Net Assets20.63B
JAMVX vs JVMSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
JAMVX vs. JVMSX commentary
May 09, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JAMVX is a Buy and JVMSX is a Buy.
FUNDAMENTALS
Fundamentals
JVMSX has more cash in the bank: 20.6B vs. JAMVX (108M). JAMVX pays higher dividends than JVMSX: JAMVX (0.99) vs JVMSX (0.46). JAMVX was incepted earlier than JVMSX: JAMVX (22 years) vs JVMSX (13 years). JVMSX (1.26) is less costly to investors than JAMVX (0.69). JVMSX is a more actively managed with annual turnover of: 47.00 vs. JAMVX (42.00). JAMVX (0) and JVMSX (0) have matching initial minimum investment requirements. JAMVX annual gain was more profitable for investors over the last year : -4.50 vs. JVMSX (-8.45). JVMSX return over 5 years is better than : 50.94 vs. JAMVX (38.73).
| JAMVX | JVMSX | JAMVX / JVMSX | |
| Total Expense Ratio | 0.68 | 1.25 | 54% |
| Annual Report Gross Expense Ratio | 0.69 | 1.26 | 55% |
| Fund Existence | 22 years | 13 years | - |
| Gain YTD | -5.212 | -2.424 | 215% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 108M | 20.6B | 1% |
| Annual Yield % from dividends | 0.99 | 0.46 | 216% |
| Returns for 1 year | -4.50 | -8.45 | 53% |
| Returns for 3 years | 1.25 | 4.66 | 27% |
| Returns for 5 years | 38.73 | 50.94 | 76% |
| Returns for 10 years | 3.10 | 27.80 | 11% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XBI | 78.04 | 0.69 | +0.89% |
| SPDR® S&P Biotech ETF | |||
| XBAP | 35.08 | 0.15 | +0.44% |
| Innovator US Eq Acltd 9 Bfr ETFTM April | |||
| MARW | 31.14 | 0.11 | +0.34% |
| AllianzIM U.S. Large Cp Buffer20 Mar ETF | |||
| DFSI | 37.11 | -0.01 | -0.02% |
| Dimensional International Sstby Cr 1 ETF | |||
| BFIX | 25.14 | -0.08 | -0.30% |
| Build Bond Innovation ETF | |||